{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "firstTradeDateMilliseconds": 1199084400000, "priceHint": 4, "epsTrailingTwelveMonths": -0.16, "epsForward": -0.2, "epsCurrentYear": -0.23, "priceEpsCurrentYear": -0.25391304, "sharesOutstanding": 166483008, "bookValue": -0.005, "fiftyDayAverage": 0.0974, "fiftyDayAverageChange": -0.039, "fiftyDayAverageChangePercent": -0.40041068, "twoHundredDayAverage": 0.1835955, "twoHundredDayAverageChange": -0.12519549, "twoHundredDayAverageChangePercent": -0.6819094, "marketCap": 10970674, "forwardPE": -0.292, "priceToBook": -11.68, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "3.0 - Hold", "tradeable": false, "cryptoTradeable": false, "regularMarketChangePercent": -0.68027097, "regularMarketPrice": 0.0584, "marketState": "REGULAR", "exchange": "FRA", "shortName": "ADAMIS PHARMACEUTIC.CORP.", "longName": "Adamis Pharmaceuticals Corporation", "messageBoardId": "finmb_41081420", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChange": -0.00039999932, "regularMarketTime": 1683892036, "regularMarketDayHigh": 0.0588, "regularMarketDayRange": "0.0584 - 0.0588", "regularMarketDayLow": 0.0584, "regularMarketVolume": 4000, "regularMarketPreviousClose": 0.0588, "bid": 0.0584, "ask": 0.0874, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 0.0588, "averageDailyVolume3Month": 67, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.013800003, "fiftyTwoWeekLowChangePercent": 0.3094171, "fiftyTwoWeekRange": "0.0446 - 0.5197", "fiftyTwoWeekHighChange": -0.4613, "fiftyTwoWeekHighChangePercent": -0.8876275, "fiftyTwoWeekLow": 0.0446, "fiftyTwoWeekHigh": 0.5197, "earningsTimestamp": 1684184400, "earningsTimestampStart": 1684184400, "earningsTimestampEnd": 1684184400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "CY3B.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "11682 El Camino Real", "address2": "Suite 300", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 997 2400", "website": "https://www.adamispharmaceuticals.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. Its products include SYMJEPI epinephrine injectable pre-filled single dose syringe products for use in the emergency treatment of acute allergic reactions comprising anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company was founded in 2006 and is headquartered in San Diego, California.", "fullTimeEmployees": 11, "companyOfficers": [{"maxAge": 1, "name": "Mr. David J. Marguglio", "age": 52, "title": "Co-Founder, CEO, Pres, Corp. Sec. & Director", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 526350, "fmt": "526.35k", "longFmt": "526,350"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. David C. Benedicto", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": {"raw": 371307, "fmt": "371.31k", "longFmt": "371,307"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Karen K. Daniels", "age": 69, "title": "VP of Operations", "yearBorn": 1953, "fiscalYear": 2012, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mark  Flather", "title": "Sr. Director of Investor Relations & Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jennifer C. Suski", "title": "Sr. Director of Marketing", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Eddie Wabern Glover", "age": 72, "title": "Chief Exec. Officer of US Compounding Inc", "yearBorn": 1950, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Robert B. Rothermel", "age": 78, "title": "Consultant", "yearBorn": 1944, "fiscalYear": 2019, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}